These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

487 related items for PubMed ID: 12622785

  • 1. Evidence for an autoimmune pathogenesis of vitiligo.
    Ongenae K, Van Geel N, Naeyaert JM.
    Pigment Cell Res; 2003 Apr; 16(2):90-100. PubMed ID: 12622785
    [Abstract] [Full Text] [Related]

  • 2. Autoimmune aspects of vitiligo.
    Kemp EH, Waterman EA, Weetman AP.
    Autoimmunity; 2001 Apr; 34(1):65-77. PubMed ID: 11681494
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Melanocyte-specific, cytotoxic T cell responses in vitiligo: the effective variant of melanoma immunity?
    Garbelli S, Mantovani S, Palermo B, Giachino C.
    Pigment Cell Res; 2005 Aug; 18(4):234-42. PubMed ID: 16029417
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Autoantibody responses to melanocytes in the depigmenting skin disease vitiligo.
    Kemp EH, Gavalas NG, Gawkrodger DJ, Weetman AP.
    Autoimmun Rev; 2007 Jan; 6(3):138-42. PubMed ID: 17289548
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Specific cytotoxic T lymphocyte responses against Melan-A/MART1, tyrosinase and gp100 in vitiligo by the use of major histocompatibility complex/peptide tetramers: the role of cellular immunity in the etiopathogenesis of vitiligo.
    Palermo B, Campanelli R, Garbelli S, Mantovani S, Lantelme E, Brazzelli V, Ardigó M, Borroni G, Martinetti M, Badulli C, Necker A, Giachino C.
    J Invest Dermatol; 2001 Aug; 117(2):326-32. PubMed ID: 11511311
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Evidence for immunologic mechanisms in human vitiligo: patients' sera induce damage to human melanocytes in vitro by complement-mediated damage and antibody-dependent cellular cytotoxicity.
    Norris DA, Kissinger RM, Naughton GM, Bystryn JC.
    J Invest Dermatol; 1988 Jun; 90(6):783-9. PubMed ID: 3373009
    [Abstract] [Full Text] [Related]

  • 12. Smyth chicken melanocyte autoantibodies: cross-species recognition, in vivo binding, and plasma membrane reactivity of the antiserum.
    Searle EA, Austin LM, Boissy YL, Zhao H, Nordlund JJ, Boissy RE.
    Pigment Cell Res; 1993 Jun; 6(3):145-57. PubMed ID: 8234200
    [Abstract] [Full Text] [Related]

  • 13. High frequency of skin-homing melanocyte-specific cytotoxic T lymphocytes in autoimmune vitiligo.
    Ogg GS, Rod Dunbar P, Romero P, Chen JL, Cerundolo V.
    J Exp Med; 1998 Sep 21; 188(6):1203-8. PubMed ID: 9743539
    [Abstract] [Full Text] [Related]

  • 14. New insights into immune mechanisms of vitiligo.
    Boniface K, Taïeb A, Seneschal J.
    G Ital Dermatol Venereol; 2016 Feb 21; 151(1):44-54. PubMed ID: 26512930
    [Abstract] [Full Text] [Related]

  • 15. [Humoral and cellular autoimmunity in genuine vitiligo studied by means of an antigen produced from melanoma cells].
    Höfs T.
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1982 Feb 21; 109(2):244-50. PubMed ID: 6179826
    [Abstract] [Full Text] [Related]

  • 16. Functional defects of peripheral regulatory T lymphocytes in patients with progressive vitiligo.
    Ben Ahmed M, Zaraa I, Rekik R, Elbeldi-Ferchiou A, Kourda N, Belhadj Hmida N, Abdeladhim M, Karoui O, Ben Osman A, Mokni M, Louzir H.
    Pigment Cell Melanoma Res; 2012 Jan 21; 25(1):99-109. PubMed ID: 21985183
    [Abstract] [Full Text] [Related]

  • 17. CD8+ T cells from vitiligo perilesional margins induce autologous melanocyte apoptosis.
    Wu J, Zhou M, Wan Y, Xu A.
    Mol Med Rep; 2013 Jan 21; 7(1):237-41. PubMed ID: 23042234
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Immune mechanisms in vitiligo.
    Bystryn JC.
    Immunol Ser; 1989 Jan 21; 46():447-73. PubMed ID: 2488866
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 25.